Matthew B. Dong

2.8k total citations · 3 hit papers
24 papers, 1.8k citations indexed

About

Matthew B. Dong is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Matthew B. Dong has authored 24 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Matthew B. Dong's work include CRISPR and Genetic Engineering (11 papers), Immune Cell Function and Interaction (8 papers) and CAR-T cell therapy research (7 papers). Matthew B. Dong is often cited by papers focused on CRISPR and Genetic Engineering (11 papers), Immune Cell Function and Interaction (8 papers) and CAR-T cell therapy research (7 papers). Matthew B. Dong collaborates with scholars based in United States, Austria and United Kingdom. Matthew B. Dong's co-authors include Sidi Chen, Ryan D. Chow, Lupeng Ye, Guangchuan Wang, Youssef Errami, Jonathan J. Park, Xiaoyun Dai, Paul Renauer, Yaying Du and Lei Peng and has published in prestigious journals such as Cell, Nature Neuroscience and Nature Biotechnology.

In The Last Decade

Matthew B. Dong

24 papers receiving 1.8k citations

Hit Papers

High-content CRISPR screening 2022 2026 2023 2024 2022 2022 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. High-content CRISPR screening
    2022 276 citations Christoph Bock, Paul Datlinger et al. Nature Reviews Methods Primers profile →
  2. High-content CRISPR screening
    2022 170 citations Christoph Bock, Paul Datlinger et al. Nature Reviews Methods Primers profile →
  3. A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy
    2022 143 citations Lupeng Ye, Jonathan J. Park et al. Cell Metabolism profile →

Peers

Matthew B. Dong
Raquel Blanco Spain
Nelly Olova United Kingdom
Charles A. Nicolette United States
Michael J. T. Stubbington United Kingdom
Raúl Torres Spain
Emma W Vaimberg United States
Eleni P. Mimitou United States
Hélène Bœuf France
Peter Gee Japan
Sonia Lameiras France
Raquel Blanco Spain
Matthew B. Dong
Citations per year, relative to Matthew B. Dong Matthew B. Dong (= 1×) peers Raquel Blanco

Countries citing papers authored by Matthew B. Dong

Since Specialization
Citations

This map shows the geographic impact of Matthew B. Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew B. Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew B. Dong more than expected).

Fields of papers citing papers by Matthew B. Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew B. Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew B. Dong. The network helps show where Matthew B. Dong may publish in the future.

Co-authorship network of co-authors of Matthew B. Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew B. Dong. A scholar is included among the top collaborators of Matthew B. Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew B. Dong. Matthew B. Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chow, Ryan D., Meizhu Bai, Matthew B. Dong, et al.. (2023). CTLA-4 tail fusion enhances CAR-T antitumor immunity. Nature Immunology. 24(9). 1499–1510. 32 indexed citations
2.
Zhang, Li, Jonathan J. Park, Matthew B. Dong, et al.. (2023). Human Gene Age Dating Reveals an Early and Rapid Evolutionary Construction of the Adaptive Immune System. Genome Biology and Evolution. 15(5). 1 indexed citations
3.
Ye, Lupeng, Jonathan J. Park, Lei Peng, et al.. (2022). A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy. Cell Metabolism. 34(4). 595–614.e14. 143 indexed citations breakdown →
4.
Peng, Lei, Zhenhao Fang, Paul Renauer, et al.. (2022). Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species. Cell Reports. 40(5). 111160–111160. 12 indexed citations
5.
Peng, Lei, Paul Renauer, Zhenhao Fang, et al.. (2022). Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2. Cell Reports Medicine. 3(5). 100634–100634. 11 indexed citations
6.
Bock, Christoph, Paul Datlinger, Florence M. Chardon, et al.. (2022). High-content CRISPR screening. Nature Reviews Methods Primers. 2(1). 276 indexed citations breakdown →
7.
Dong, Matthew B., et al.. (2021). Tumor immunology CRISPR screening: present, past, and future. Trends in cancer. 8(3). 210–225. 22 indexed citations
8.
Wang, Guangchuan, Ryan D. Chow, Lvyun Zhu, et al.. (2020). CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade. Cancer Discovery. 10(12). 1912–1933. 87 indexed citations
9.
Yuan, Shuai, Lei Peng, Jonathan J. Park, et al.. (2020). Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA. Molecular Cell. 80(6). 1055–1066.e6. 134 indexed citations
10.
Ye, Lupeng, Jonathan J. Park, Matthew B. Dong, et al.. (2019). In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma. Nature Biotechnology. 37(11). 1302–1313. 148 indexed citations
11.
Wang, Guangchuan, Ryan D. Chow, Zhigang Bai, et al.. (2019). Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity. Nature Immunology. 20(11). 1494–1505. 88 indexed citations
12.
Chow, Ryan D., Guangchuan Wang, Lupeng Ye, et al.. (2019). In vivo profiling of metastatic double knockouts through CRISPR–Cpf1 screens. Nature Methods. 16(5). 405–408. 42 indexed citations
13.
Dong, Matthew B., Guangchuan Wang, Ryan D. Chow, et al.. (2019). Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. Cell. 178(5). 1189–1204.e23. 213 indexed citations
14.
Renauer, Paul, Guangchuan Wang, Ryan D. Chow, et al.. (2019). Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo. Cell Systems. 8(2). 136–151.e7. 12 indexed citations
15.
Wang, Guangchuan, Ryan D. Chow, Lupeng Ye, et al.. (2018). Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR–mediated direct in vivo screening. Science Advances. 4(2). eaao5508–eaao5508. 72 indexed citations
16.
Chow, Ryan D., Christopher D. Guzman, Guangchuan Wang, et al.. (2017). AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. Nature Neuroscience. 20(10). 1329–1341. 175 indexed citations
17.
18.
Ji, Ming, Meenal Sinha, Matthew B. Dong, et al.. (2016). Determinants of Divergent Adaptive Immune Responses after Airway Sensitization with Ligands of Toll-Like Receptor 5 or Toll-Like Receptor 9. PLoS ONE. 11(12). e0167693–e0167693. 20 indexed citations
19.
Dong, Matthew B., M. Jubayer Rahman, & Kristin V. Tarbell. (2015). Flow cytometric gating for spleen monocyte and DC subsets: differences in autoimmune NOD mice and with acute inflammation. Journal of Immunological Methods. 432. 4–12. 25 indexed citations
20.
Tong, Ming, Matthew B. Dong, & Suzanne M. de la Monte. (2009). Brain Insulin-Like Growth Factor and Neurotrophin Resistance in Parkinson's Disease and Dementia with Lewy Bodies: Potential Role of Manganese Neurotoxicity. Journal of Alzheimer s Disease. 16(3). 585–599. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raquel Blanco Breakdown of academic impact, for papers by Nelly Olova Breakdown of academic impact, for papers by Charles A. Nicolette Breakdown of academic impact, for papers by Michael J. T. Stubbington Breakdown of academic impact, for papers by Raúl Torres Breakdown of academic impact, for papers by Emma W Vaimberg Breakdown of academic impact, for papers by Eleni P. Mimitou Breakdown of academic impact, for papers by Hélène Bœuf Breakdown of academic impact, for papers by Peter Gee Breakdown of academic impact, for papers by Sonia Lameiras
Rankless by CCL
2026